The pathogenesis of atherosclerosis and plaque instability

Atherosclerosis and Oxidant Stress: A New Perspective

Volumn , Issue , 2008, Pages 1-10

  Forrester, James S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885695133     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-72347-1_1     Document Type: Chapter

References (56)

1. Forrester JS, Litvack F, Grundfest W, Hickey A. A Perspective of Coronary Disease seen Through the Arteries of Living Man. Circulation 1987;75:505-513. (Pubitemid 17026038)
2. Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, Chaux A, Kass R, Blanche C, Matloff J, Morgenstern L, Forrester JS. Coronary Angioscopy in Patients with Unstable Angina Pectoris. N Engl J Med 1986 Oct 9;315(15):913-919. (Pubitemid 16023677)
3. Davies MJ. The Composition of Coronary-Artery Plaques. N Engl J Med 1997;336(18):1312-1314.
4. Felton CV, Crook D, Davies MJ, Oliver MF. Relation of Plaque Lipid Composition and Morphology to the Stability of Human Aortic Plaques. Arterioscler Thromb Vasc Biol 1997;17(7):1337-1345. (Pubitemid 27329858)
5. Shechter M, Sharir M, Forrester J, Bairey-Merz CN. Is There a Benefit to Lowering Low-Density Lipo protein Below 100 Mg/Dl in Patients with Coronary Artery Disease. JACC 1999;33:271A.
6. Mellwig KP, Baller D, Gleichmann U, Moll D, Betker S, Weise R, Notohamiprodjo G. Improvement of Coronary Vasodilatation Capacity Through Single LDL Apheresis. Atherosclerosis 1998 Jul;139(1):173-178. (Pubitemid 28341880)
7. Vogel, RA. Cholesterol Lowering and Endothelial Function. Am J Med 1999;107(5):479-487. (Pubitemid 29528337)
8. Topper JN, Cai J, Falb D, et al. Identification of Vascular Endothelial Genes Differentially Responsive to Fluid Mechanical Stimuli: Cyclooxygenase-2, Manganese Superoxide Dismutase, and Endothelial Cell Nitric Oxide Synthase are Selectively Up-Regulated by Steady Laminar Shear Stress. Proc Natl Acad Sci USA 1996;93:10417-10422.
9. De Caterina R, Libby P, Peng HB, et al. Nitric Oxide Decreases Cytokine-Induced Endothelial Activation: Nitric Oxide Selectively Reduces Endothelial Expression of Adhesion Molecules and Proinflammatory Cytokines. J Clin Invest 1995;96:60-68.
10. Nagel T, Resnick N, Atkinson WJ, et al. Shear Stress Selectively Upregulates Intercellular Adhesion Molecule-1 Expression in Cultured Human Vascular Endothelial Cells. J Clin Invest 1994;94:885-891.
11. Qiao JH, Tripathi J, Mishra NK, et al. Role of Macrophage Colony-Stimulating Factor in Atherosclerosis: Studies of Osteopetrotic Mice. Am J Pathol 1997;150:1687-1699. (Pubitemid 27193816)
12. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The Combined Role of P and E-Selectins in Atherosclerosis. J Clin Invest 1998;102(1):145-152.
13. Van der Wal AC, Das PK, Tigges AJ. Adhesion Molecules on the Endothelium and Mononuclear Cells in Human Atherosclerotic Lesions. Am J Pathol 1992;141:1427-1433. (Pubitemid 23002626)
14. Rohde L, Lee RT, Rivero J, Jamacochian M, Arroyo L, Briggs W, Rifai N, Libby P, Creager M, Ridker P. Circulating Cell Adhesion Molecules Are Correlated with Ultrasound-Based Assessment of Carotid Atherosclerosis. Arterioscler Thromb Vasc Biol 1998;18(11):1765-1770 (Pubitemid 28521067)
15. Avogaro P, Bigitolo BG, Cassolato G. Presence of a Modified Low Density Lipoprotein in Humans. Arteriosclerosis 1998;8:79-87.
16. Hasegawa A, Toshima S, Nakano A, Nagai R. Oxidized LDL in patients with coronary heart disease and normal subjects. Nippon Rinsho 1999;57(12):2754-2758.
17. Steinberg D. Low Density Lipoprotein Oxidation and its Pathobiological Significance. J Biol Chem 1997;272:20963-20966. (Pubitemid 27373946)
18. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Friday KE, Rothblat G. A Cell Culture System of Screening Human Serum for Ability to Promote Cellular Cholesterol Efflux. Arteriosclerosis, Thrombosis 1994;14:1056-1065.
19. Woollett LA, Kearney DM, Spady DK. Diet Modification Alters Plasma HDL Cholesterol Concentrations but not the Transport of HDL Esters to the Liver in the Hamster. J Lipid Res 1997;38:2289-2302. (Pubitemid 27495388)
20. Barter PJ. Inhibition of Endothelial Cell Adhesion Molecular Expression by High Density Lipoproteins. Clin Exp Pharmacol Physiol 1997;24(3/4):286-287. (Pubitemid 27187414)
21. Bonnefont-Rousselot D, Therond P, Beaudeux JL, Peynet J, Legrand A, Delattre J. High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis. Clin Chem Lab Med 1999;37(10):939-948. (Pubitemid 30011571)
22. Forrester JS, Shah PK. Lipid lowering vs. revascularization: An idea whose time (for testing) has come. Circulation 1997;96(4):1360-1362. (Pubitemid 27344244)
23. Galis Z, Sukhova G, Kranzhofer R, Clark S, Libby P. Macrophage Foam Cells from Experimental Atheroma Constitutively Produce Matrix-Degrading Proteinases. Proc Natl Acad Sci USA 1995;92:402-406.
24. Barath P, Jakubowski A, Fishbein M, Grundfest W, Litvack F, Forrester J. Are Mast Cells the Culprit in Coronary Plaque Destabilization? J Am Coll Cardiol 1988;9:II-52.
25. Kaartinen M, Penttila A, Kovanen P. Mast Cells in Rupture-Prone Areas of Human Coronary Atheromas Produce and Store TNF-α. Circulation 1996;94:2787-2792. (Pubitemid 26411742)
26. Chen Y-H, Chen Y-L, Lin S-J, Chou C-Y, Mar G-Y, Chang M-S, Wang S-P. Electron Microscopic Studies of Phenotypic Modulation of Smooth Muscle Cells in Coronary Arteries of Patients With Unstable Angina Pectoris and Post-angioplasty Restenosis. Circulation 1997;95:1169-1175. (Pubitemid 27097827)
27. Libby P. Molecular Bases of the Acute Coronary Syndromes. Circulation 1995;91(11):2844-2850.
28. van der Wal AC, Becker AE, van der Loos CM,Das PK. Unstable Plaques, Endothelial Function, and Coronary Artery Thrombosis: Site of Intimal Rupture or Erosion of Thrombosed Coronary Atherosclerotic Plaques is Characterized by an Inflammatory Process Irrespective of the Dominant Plaque Morphology. Circulation 1994;89:36-44. (Pubitemid 24026469)
29. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and Localization of Tumor Necrosis Factor Gene Expression in Human Atheroma. Am J Cardiol 1990;65:297-302. (Pubitemid 20038909)
30. Sukhova G, Schonbeck U, Rabkin E, Schoen F, Poole A, Billinghurst R, Libby P. Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and-3 in Vulnerable Human Atheromatous Plaques. Circulation 1999;99(19):2503- 2509. (Pubitemid 29228279)
31. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Marin JL, Betriu A, Sanz G. Elevation of Serum Levels of the Anti-Inflammatory Cytokine. Interleukin-10 and Decreased Risk of Coronary Events in Patients with Unstable Angina. Am Heart J 2002;144:811-817. (Pubitemid 35335172)
32. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G. Distinct Patterns of Transforming Growth Factor-β Isoform and Receptor Expression in Human Atherosclerotic Lesions. Circulation 1999;99:2883-2891.
33. Ross R. Atherosclerosis is an Inflammatory Disease. Am Heart J 1999;138:S419-S420. (Pubitemid 29523224)
34. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal Detection of Cellular Infiltrates in Living Atherosclerotic Plaques: Possible Implications for Plaque Rupture and Thrombosis. Lancet 1996;347:1447-1449. (Pubitemid 26161208)
35. Malik IS, Haskard DO. Soluble Adhesion Molecules in Ischaemic Heart Disease. Eur Heart J 1999;20:990-991. (Pubitemid 29306779)
36. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J. Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results from a Large Population Study. Circulation 2001 Feb 27;103(8):1064-1070. (Pubitemid 32200178)
37. Danesh J. Smoldering Arteries?: Low-grade Inflammation and Coronary Heart Disease. JAMA 1999;282(22):2169-2171.
38. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human Monocyte-Derived Macrophages Induce Collagen Breakdown in Fibrous Caps of Atherosclerotic Plaques: Potential Role of Matrix-Degrading Metalloproteinases and Implication for Plaque Rupture. Circulation 1995;95:1565-1569.
39. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kd Gelatinase in Human Coronary Atherosclerotic Lesions: Association of Active Enzyme Synthesis with Unstable Angina. Circulation 1995;95:2125-2131.
40. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic Plaque Caps are Locally Weakened When Macrophage Density is Increased. Atherosclerosis 1991;87:87-90.
41. Xu XP, Meisel SR, Ong HM, Kaul S, Cercek B, Rajavashisth TB, Sharifi B, Shah PK. Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and is Tissue Inhibitor in Human Monocyte-Derived Macrophages. Circulation 1999;99:993-998. (Pubitemid 29104486)
42. Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-beta Selectively Induce Expression of 92-kDa Gelatinase by Human Macrophages. J Immunol 1996;157:4159-4165. (Pubitemid 126449330)
43. Rajavashisth, TB, Xu X-P, Jovinge S, Meisel S, Xu X-O, Chai N-N, Fishbein MC, Kaul S, Cercek B, Sharifi B. Shah PK. Membrane Type 1 Membrane Type 1 Matrix Metalloproteinase Expression in Human Atherosclerotic Plaques: Evidence for Activation by Proinflammatory Mediators. Circulation 1999;99(24):3103-3109. (Pubitemid 29289074)
44. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive Oxygen Species Produced by Macrophage-Derived Foam Cells Regulate the Activity of Vascular Matrix Metalloproteinases in Vitro: Implications for Atherosclerotic Plaque Stability. J Clin Invest 1996;98:2572-2579. (Pubitemid 26415078)
45. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression. Circulation 1998;98:300-307. (Pubitemid 28348051)
46. Bennett MR, Evan GI, Schwartz SM. Apoptosis of Human Vascular Smooth Muscle Cells Derived from Normal Vessels and Coronary Atherosclerotic Plaque. J Clin Invest 1995;95:2266-2274.
47. Henderson EL, Geng Y-J, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of Smooth Muscle Cells and Expression of Mediators of Apoptosis by T Lymphocytes in Human Abdominal Aneurysms. Circulation 1999;99:96-104. (Pubitemid 29035963)
48. Wallner K, Li C, Shah PK, Fishbein MC, Forrester JS, Kaul S, Sharifi B. Tenascin-C is Expressed in Macrophage-Rich Human Coronary Atherosclerotic Plaque. Circulation 1999;99(10):1284-1289. (Pubitemid 29129911)
49. LaFleur DW, Chiang J, Fagin JA, Forrester JS, Shah PK, Sharifi BG. Smooth Muscle Cells Interact with Tenascin Through its Fibrinogen-Like Domain. FASEB 1998;12(4):A479. (Pubitemid 128783493)
50. Falk E, Shah P, Fuster V. Coronary Plaque Disruption. Circulation 1995;92:657-671.
51. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques. Circulation 1997;95:594-599. (Pubitemid 27063034)
52. Forrester JS, Kaul S, Bairey-Merz N. The Aggressive Lipid Lowering Controversy. J Am Coll Cardiol 2000;36:1419-1425.
53. Packard CJ. Relationship Between LDL-C Changes and CHD Event Reduction with Pravastatin In the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1997;96(suppl I):I-107.
54. deLorgeril M, Salen P, Martin J-L, Monjaud I, Delaye J, Mamelle N. Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction. Circulation 1999;99:779-785. (Pubitemid 29083018)
55. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt T, Wittes J. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol. New Engl J Med 1999;341(6):410-418. (Pubitemid 29362514)
56. Relation of gemfibrozil treatment and lipid levels with major coronary exacts; VA-HIT; a randomized controlled trial 2001;285:1585-1591.